AstraZeneca revives Cambridge investment after UK agrees to pay more for drugs
Resumption of £300mn in UK projects is a result of trade deal with US that aims to increase medicines spending
Related reading
AstraZeneca bounces back from scandal in China
Pharma group has installed new leadership in the country and pledged $2.5bn for a Beijing R&D centre
US urged UK to offer better drug pricing deal to pharma companies
Ambassador’s meeting with chancellor Rachel Reeves came days before AstraZeneca and Merck paused projects in Britain
Britain is squeezing AstraZeneca too tight
NHS curbs on drug prices have alienated UK pharma companies and become self-defeating
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
AstraZeneca strikes deal to lower drug costs in exchange for tariff reprieve
Chief executive Pascal Soriot applauds the deal with Donald Trump as ‘a big win’ for US patients
AstraZeneca strikes $4.7bn China deal to boost weight-loss drugs pipeline
Drugmaker expands push into fast-growing market